Cullinan Therapeutics Inc Share Price

NASDAQ: CGEM

Small Cap

$6.25

+0.32

(+5.40%)

Live

as on September 18, 2025 at 7:41 pm IST

$₹

Cullinan Therapeutics Inc Stock Performance

as on September 18, 2025 at 7:41 pm IST

Day's Low
Day's High
$6.01
Day's Price Range
$6.19
$6.25
3.84%
Downside
-0.96%
Upside
52 Week's Low
52 Week's High
$5.89
52-Week Price Range
$18.62
$6.25
5.76%
Downside
197.92%
Upside

Cullinan Therapeutics Inc share price movements today

Previous Close: $5.93
Open: $6.01
Volume: 93.2K
Day's Low - High: $6.01 - $6.19
52 Week Low - High: $5.89 - $18.62

Cullinan Therapeutics Inc Historical Returns

1 Month Return: -25.41 %
3 Month Return: -27.33 %
1 Year Return: -65.58 %
3 Year Return: -52.52 %
5 Year Return: 0 %

Cullinan Therapeutics Inc Stock Fundamentals & Key Indicators

Check Cullinan Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$371.6M

EPS (TTM)

-3.674

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

P/B Ratio

0

PEG Ratio

0

EBITDA

-234.4M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

1396900.00%

Cullinan Therapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Cullinan Therapeutics Inc with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Cullinan Therapeutics Inc	BUY	$371.6M	NA	NA	0.00%
Alnylam Pharmaceuticals, Inc.	BUY	$60.5B	241.54%	-505.15	-12.96%
Beone Medicines Ltd	NA	$38.7B	NA	NA	-3.89%
Vertex Pharmaceuticals Incorporated	BUY	$99.3B	45.88%	27.56	31.86%
Regeneron Pharmaceuticals, Inc.	BUY	$60.9B	5.45%	14.49	31.37%

Stock Returns calculator for Cullinan Therapeutics Inc Stock including INR - Dollar returns

The Cullinan Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

1Y
3Y

Cullinan Therapeutics Inc investment value today

Current value as on today

₹41,227

Returns

₹58,773

(-58.77%)

Returns from Cullinan Therapeutics Inc Stock

₹63,726 (-63.73%)

Dollar Returns*

₹4,953 (+4.95%)

Analyst Recommendation on Cullinan Therapeutics Inc Stock

Based on 14 analysts

BUY

92.86%

Buy

7.14%

Hold

0.00%

Sell

Based on 14 analysts, 92.86% of analysts recommend a 'BUY' rating for Cullinan Therapeutics Inc. Average target price of $26.22

Cullinan Therapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Cullinan Therapeutics Inc.

What analysts predicted

76.16%UPSIDE

Target Price

$26.22

Current Price

$6.25

Analyzed by

14 Analysts

Target

$26.22

Cullinan Therapeutics Inc target price $26.22, a slight upside of 76.16% compared to current price of $6.25. According to 14 analysts rating.

Cullinan Therapeutics Inc Stock's Interest Amongst Investors

Search interest for Cullinan Therapeutics Inc Stock has increased by 150% in the last 30 days, reflecting an upward trend in search activity.

Time period: August 19, 2025 to September 18, 2025

Change:150% versus previous 30 day period

Cullinan Therapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Total Revenue	-	-	-	-	-	-	-	-	-	-
Gross Profit	0	0	0	0	0	0	0	0	0	0
Operating Income	-62	-37	-45	-45	-42	-50	-48	-55	-54	-75
EBITDA	-62	-37	-44	-45	-42	-49	-48	-54	-54	-75
Interest Expense	4	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-58	-32	-39	-39	-37	-42	-40	-47	-48	-70
Income Tax Expense	0	-5	-5	-14	0	-	-	0	-	-
Net Income	-57	-32	-39	-23	-37	-42	-40	-47	-48	-70
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Cullinan Therapeutics Inc Annual Profit & Loss

All numbers in Millions USD

	Dec 2014	Dec 2015	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Revenue	-	-	-	-	-	18	18	-	-	-
Gross Profit	-	-	-	0	0	0	18	0	0	0
Operating Income	0	0	0	-14	-22	-60	-67	-132	-191	-196
EBITDA	-	-	-	-14	-22	-60	-67	151	-190	-167
Interest Expense	-	-	-	-	-	0	65	562	-	-
Depreciation	-	-	-	0	0	0	0	0	0	0
Income Before Tax	0	0	0	-14	-21	-59	-67	151	-169	-167
Income Tax Expense	-	-	-	0	-1	-8	-2	42	-14	0
Net Income	0	0	0	-14	-20	-50	-65	111	-153	-167
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	-268.43%	-343.35%	0.00%	0.00%	0.00%

Cullinan Therapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025
Net Income	-32	-39	-23	-37	-42	-40	-47	-48	-70
Operating Cash Flow	-31	-34	-18	-38	-36	-34	-36	-43	-57
Investing Cash Flow	12	-42	51	12	-185	19	15	36	53
Financing Cash Flow	38	0	0	1	262	1	1	-	0
Change in Cash	19	-76	33	-24	40	-12	-19	-6	-3

Cullinan Therapeutics Inc Annual Cash Flow

All numbers in Millions USD

	Dec 2015	Dec 2016	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Net Income	0	0	-14	-21	-59	-67	109	-153	-167
Operating Cash Flow	0	0	-13	-20	-29	-43	-126	-134	-145
Investing Cash Flow	-	-	0	-35	-5	-333	248	35	-136
Financing Cash Flow	0	0	0	85	140	268	-25	40	266
Change in Cash	0	0	-13	29	104	-108	96	-57	-15

Global Institutional Holdings in Cullinan Therapeutics Inc

Funds	Holdings
MPM Oncology Impact Management LP	12.95%
Bvf Inc	9.73%
BlackRock Inc	7.14%
Deerfield Management Co	6.54%
Vanguard Group Inc	5.15%

See all

Insights on Cullinan Therapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 111.5% return, outperforming this stock by 164.0%
NO EFFECT
Against Peers
In the last 1 year, Beone Medicines Ltd has given 68.4% return, outperforming this stock by 134.0%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CGEM stock has moved down by -10.4%

About Cullinan Therapeutics Inc

cullinan oncology is focused on investing in and developing a highly diversified portfolio of oncology therapeutics with a unique, cost-efficient business model. sourced from the cullinan dry lab as well as external collaborators, cullinan’s assets are managed by a single, highly experienced team of oncology professionals and drug developers across a lean, capital efficient operating model.

Organisation	Cullinan Therapeutics Inc
Headquarters	One Main Street, Cambridge, MA, United States, 02142
Industry	Other Consumer Services
CEO	Mr. Nadim Ahmed
E-voting on shares	Click here to vote

Key Management of Cullinan Therapeutics Inc

Name	Title
Ms. Mary Kay Fenton CPA	Chief Financial Officer
Dr. Jeffrey Jones M.B.A., M.D., M.P.H.	Chief Medical Officer
Dr. Patrick A. Baeuerle Ph.D.	Co-Founder, Chief Scientific Advisor & Chairman of Scientific Advisory Board
Dr. Jennifer Michaelson Ph.D.	Chief Scientific Officer
Dr. Corinne Savill Ph.D.	Chief Business Officer
Mr. Nadim Ahmed	President, CEO & Director
Nicholas Smith	Head of Investor Relations
Ms. Jacquelyn L. Sumer J.D.	Chief Legal Officer, Chief Compliance Officer & Corporate Secretary
Mr. Steve Andre	Chief Human Resources Officer
Ms. Rose Weldon	Senior Vice President of Corporate Affairs

FAQs

What is Cullinan Therapeutics Inc share price today?

Cullinan Therapeutics Inc share price today is $6.25 as on September 18, 2025 at 7:41 pm IST. Cullinan Therapeutics Inc share today touched a day high of $6.19 and a low of $6.01.

What is the 52 week high and 52 week low for Cullinan Therapeutics Inc share?

Cullinan Therapeutics Inc share touched a 52 week high of $18.62 on September 20, 2024 and a 52 week low of $5.89 on September 17, 2025. Cullinan Therapeutics Inc stock price today i.e. September 18, 2025 at 7:41 pm IST is trending at $6.25,which is 66.43% down from its 52 week high and 6.11% up from its 52 week low.

What is Cullinan Therapeutics Inc's market capitalisation today?

Cullinan Therapeutics Inc market capitalisation is $0.00T as on September 18, 2025 at 7:41 pm IST.

How to invest in Cullinan Therapeutics Inc Stock (CGEM) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Cullinan Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Cullinan Therapeutics Inc Shares that will get you 0.2400 shares as per Cullinan Therapeutics Inc share price of $6.25 per share as on September 18, 2025 at 7:41 pm IST.

What is the minimum amount required to buy Cullinan Therapeutics Inc Stock (CGEM) from India?

Indian investors can start investing in Cullinan Therapeutics Inc (CGEM) shares with as little as ₹88.114 or $1 (as of September 18, 2025 at 7:42 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹881.14 in Cullinan Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on September 18, 2025 at 7:42 pm IST). Based on Cullinan Therapeutics Inc share’s latest price of $6.25 as on September 18, 2025 at 7:41 pm IST, you will get 1.6000 shares of Cullinan Therapeutics Inc. Learn more about fractional shares .